# EDGAR Filing Document

**Accession Number:** 0001367083
**File Stem:** 0001683168-26-003140
**Filing Date:** 2026-4
**Character Count:** 2201
**Document Hash:** a3a0d73530cac92e41714b288fdfafc2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-26-003140.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001683168-26-003140

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260422

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sonoma Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001367083
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 680423298
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 5445 CONESTOGA COURT, SUITE 150
- **CITY:** BOULDER
- **STATE:** CO
- **ZIP:** 80301
- **BUSINESS PHONE:** 800-759-9305

**MAIL ADDRESS:**
- **STREET 1:** 5445 CONESTOGA COURT, SUITE 150
- **CITY:** BOULDER
- **STATE:** CO
- **ZIP:** 80301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Oculus Innovative Sciences, Inc.
- **DATE OF NAME CHANGE:** 20060622

![](logo.jpg)

April 22, 2026

<u>VIA EDGAR</u>

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attn: J. Conlon Danberg

---

| | |
|:---|:---|
| Re: | Sonoma Pharmaceuticals, Inc. |
|  | Registration Statement on Form S-1/A |
|  | Filed April 22, 2026 |
|  | File No. 333-295171<br>|

---

<u>Acceleration Request</u>

Requested Date: April 23, 2026

Requested Time: 5:00 P.M. Eastern Standard Time

Dear Mr. Danberg:

Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the "Company"), hereby requests that the above-captioned Registration Statement on Form S-1 (the "Registration Statement") be accelerated to April 23, 2026 at 5:00pm EST or as soon as practicable thereafter.

The cooperation of the staff in meeting the Company's request is very much appreciated. Please contact me if you have any questions or if we can otherwise be of assistance to you.

Sincerely,

/s/ Amy Trombly

Amy Trombly, Esq.

5445 Conestoga Court<br> Suite 150<br> Boulder, Colorado 80301<br> sonomapharma.com<br> NASDAQ: SNOA<br>